56 related articles for article (PubMed ID: 2068153)
1. Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.
Munn DH; Cheung NK
Prog Clin Biol Res; 1991; 366():389-94. PubMed ID: 2068153
[No Abstract] [Full Text] [Related]
2. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF.
Schmid I; Baldwin GC; Jacobs EL; Isacescu V; Neagos N; Giorgi JV; Glaspy JA
Cytometry; 1995 Jun; 22(2):103-10. PubMed ID: 7587740
[TBL] [Abstract][Full Text] [Related]
3. Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy.
Bajorin DF; Cheung NK; Houghton AN
Semin Hematol; 1991 Apr; 28(2 Suppl 2):42-8. PubMed ID: 1829550
[No Abstract] [Full Text] [Related]
4. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
5. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
6. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
7. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
Blanchard DK; Serbousek D; Djeu JY
Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
Munn DH; Cheung NK
J Exp Med; 1990 Jul; 172(1):231-7. PubMed ID: 2193096
[TBL] [Abstract][Full Text] [Related]
9. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
Munn DH; Cheung NK
J Exp Med; 1989 Aug; 170(2):511-26. PubMed ID: 2526848
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone.
Buchwald UK; Geerdes-Fenge HF; Vöckler J; Ziege S; Lode H
Eur J Med Res; 1999 Mar; 4(3):85-94. PubMed ID: 10085274
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
Ericson SG; Benoit NE; Mills LE; Fanger MW
Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291
[TBL] [Abstract][Full Text] [Related]
14. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes.
Hashimoto S; Yoda M; Yamada M; Yanai N; Kawashima T; Motoyoshi K
Exp Hematol; 1996 Feb; 24(2):123-8. PubMed ID: 8641333
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
Thomassen MJ; Barna BP; Wiedemann HP; Ahmad M
J Biol Response Mod; 1990 Feb; 9(1):87-91. PubMed ID: 2156955
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
Young DA; Lowe LD; Clark SC
J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
[TBL] [Abstract][Full Text] [Related]
18. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony stimulating factor stimulates rapid phosphorylation of proteins on tyrosines in human U937 and HL-60 leukemic cells.
Adunyah SE
Biochem Biophys Res Commun; 1993 Jun; 193(3):890-6. PubMed ID: 7686754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
